North Bridge Venture Partners V-B LP's Form 4 filing
Lyra Therapeutics, Inc. (LYRA) · filed Jun 2, 2023
- Accession no.
- 0000899243-23-014352
- Filed
- Jun 2, 2023, 4:15 PM ET
- Trade date
- May 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market purchases total $4.39M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| North Bridge Venture Partners V-B LPCIK 0001138399 | 10% Owner |
| North Bridge Venture Partners V A LPCIK 0001138402 | 10% Owner |
| Damore Richard ACIK 0001206641 | 10% Owner |
| North Bridge Venture Management V, L.P.CIK 0001297397 | 10% Owner |
| North Bridge Venture Partners VI L PCIK 0001327539 | 10% Owner |
| NBVM GP, LLCCIK 0001401650 | 10% Owner |
| North Bridge Venture Management VI, L.P.CIK 0001590898 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Common Stock | PPurchaseAcquired | +403,858 | $2.43 | +$981,374.94 | 2,259,301 | Indirect | Duplicate filing |
| May 31, 2023 | Common Stock | PPurchaseAcquired | +197,946 | $2.43 | +$481,008.78 | 1,107,370 | Indirect | Duplicate filing |
| May 31, 2023 | Common Stock | PPurchaseAcquired | +1,203,612 | $2.43 | +$2,924,777.16 | 2,521,745 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Common Stock | PPurchaseAcquired | +201,929 | $0.125 | +$25,241.13 | 201,929 | Indirect | Duplicate filing |
| May 31, 2023 | Common Stock | PPurchaseAcquired | +98,973 | $0.125 | +$12,371.63 | 98,973 | Indirect | Duplicate filing |
| May 31, 2023 | Common Stock | PPurchaseAcquired | +601,806 | $0.125 | +$75,225.75 | 601,806 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.